Information on how to access Mylotarg™▼ (gemtuzumab ozogamicin) and cytarabine prescribing information and adverse event reporting can be found at the bottom of the page.
Please view MYLOTARG SmPC for more information
Download the Pharmacy booklet which is a guide to treatment with MYLOTARG. SmPC should be consulted for full guidance.
Download Pharmacy Guide
Download the fast facts PDF document to aid your understanding of MYLOTARG
View Fast Facts PDF
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AML, acute myeloid leukaemia; ANC, absolute neutrophil count; AST, aspartate aminotransferase; IV, intravenous; SmPC, Summary of Product Characteristics; UV, ultraviolet; VOD, veno-occlusive disease.
Dosing Guide
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020
No